SE
60
-3
A
37
-2
HCA
48
-2
C
62
4
KR
36
-6
PLD
45
-5
AA
56
15
OMC
50
-16
CRM
60
-7
OI
42
-3
WDC
37
-3
FTI
71
-7
MRO
50
4
VMC
53
-4
HPE
44
-2
PGR
59
-3
UPS
48
2
AEP
54
6
SLG
57
-3
AMGN
42
-4
SE
60
-3
A
37
-2
HCA
48
-2
C
62
4
KR
36
-6
PLD
45
-5
AA
56
15
OMC
50
-16
CRM
60
-7
OI
42
-3
WDC
37
-3
FTI
71
-7
MRO
50
4
VMC
53
-4
HPE
44
-2
PGR
59
-3
UPS
48
2
AEP
54
6
SLG
57
-3
AMGN
42
-4
Financhill
Back

The Estee Lauder Companies Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
15

EL
The Estee Lauder Companies

Last Price:
63.75
Seasonality Move:
7.96%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
15
The Estee Lauder Companies (EL) is a Sell

Is The Estee Lauder Companies a Buy, Sell or Hold?

  • The current The Estee Lauder Companies [EL] share price is $63.75. The Score for EL is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
  • EL is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EL Stock Price Chart

What is The Estee Lauder Companies's stock price today?

  • The The Estee Lauder Companies share price today is $63.75
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EL is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

EL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -7.3 Sell
Relative Strength Index (14 RSI): 26.48 Sell
Chaikin Money Flow: -1878289 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (65.3 - 90.54) Sell
Bollinger Bands (100): (79.67 - 102.53) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

EL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 64.03 Sell
20-day SMA: 74.26 Sell
50-day SMA: 84.59 Sell
200-day SMA: 114.5 Sell
8-day EMA: 65.37 Sell
20-day EMA: 72.34 Sell
50-day EMA: 82.09 Sell
200-day EMA: 109.21 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

The Estee Lauder Companies Earnings Growth & EL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.49 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.12 per share, and a decrease next year of $0.58 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

The Estee Lauder Companies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):